|
|
|
Insider
Information: |
Ricks David A |
Relationship: |
Director |
City: |
Indianapolis |
State: |
IN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
481,225 |
|
Indirect Shares
|
144,309 |
|
|
Direct
Value |
$399,904,288 |
|
|
Indirect Value
|
$118,355,154 |
|
|
Total
Shares |
625,534 |
|
|
Total
Value |
$518,259,443 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
75.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Eli Lilly & Co |
LLY |
President, Chair, and ... |
2024-02-12 |
479,250 |
2024-02-12 |
139,637 |
Premium* |
|
Adobe Systems Inc |
ADBE |
Director |
2024-04-17 |
1,975 |
2024-04-17 |
4,672 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2015-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,591 |
73,994 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2015-02-02 |
4 |
AS |
$71.51 |
$341,031 |
D/D |
(4,769) |
63,285 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2015-02-04 |
4 |
AS |
$69.99 |
$220,259 |
D/D |
(3,147) |
60,138 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2015-03-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
183 |
61,017 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2015-07-23 |
5 |
GD |
$0.00 |
$0 |
D/D |
12 |
61,005 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2015-11-05 |
4 |
OE |
$56.18 |
$279,215 |
D/D |
4,970 |
65,108 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2015-11-05 |
4/A |
D |
$81.05 |
$316,743 |
D/D |
(3,908) |
61,200 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2015-11-05 |
4 |
D |
$81.05 |
$318,040 |
D/D |
(3,924) |
61,184 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2015-12-17 |
5 |
GD |
$0.00 |
$0 |
D/D |
72 |
60,933 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2016-01-26 |
4 |
A |
$81.96 |
$1,558,551 |
D/D |
19,016 |
79,949 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2016-02-01 |
4 |
AS |
$78.36 |
$256,472 |
D/D |
(3,273) |
81,863 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2016-02-01 |
4 |
D |
$79.10 |
$368,290 |
D/D |
(4,656) |
85,136 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2016-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,843 |
89,792 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2016-02-03 |
4 |
AS |
$76.73 |
$188,756 |
D/D |
(2,460) |
79,403 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2017-01-27 |
4 |
A |
$75.38 |
$1,521,395 |
D/D |
20,183 |
99,156 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2017-02-01 |
4 |
D |
$77.03 |
$372,594 |
D/D |
(4,837) |
104,563 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2017-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,244 |
109,400 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2017-05-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
357 |
107,076 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2017-06-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
25 |
107,433 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2017-12-03 |
4 |
D |
$85.32 |
$221,917 |
D/D |
(2,601) |
107,458 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2017-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,496 |
110,059 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2018-01-29 |
4 |
A |
$87.60 |
$1,086,853 |
D/D |
12,407 |
119,483 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2018-02-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,764 |
119,486 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2018-02-01 |
4 |
D |
$81.45 |
$778,581 |
D/D |
(9,559) |
131,250 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2018-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,326 |
140,809 |
0 |
- |
|
74 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|